These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28777254)

  • 1. T-type and L-type Calcium Channel Blockers for the Treatment of Cardiac Iron Overload: An Update.
    Kumfu S; Chattipakorn SC; Chattipakorn N
    J Cardiovasc Pharmacol; 2017 Nov; 70(5):277-283. PubMed ID: 28777254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyopathy associated with iron overload: how does iron enter myocytes and what are the implications for pharmacological therapy?
    Wijarnpreecha K; Kumfu S; Chattipakorn SC; Chattipakorn N
    Hemoglobin; 2015; 39(1):9-17. PubMed ID: 25572185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice.
    Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
    Exp Physiol; 2016 Apr; 101(4):521-39. PubMed ID: 26824522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload and apoptosis of HL-1 cardiomyocytes: effects of calcium channel blockade.
    Chen MP; Cabantchik ZI; Chan S; Chan GC; Cheung YF
    PLoS One; 2014; 9(11):e112915. PubMed ID: 25390893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of L-type calcium channel blocker (amlodipine) on myocardial iron deposition in patients with thalassaemia with moderate-to-severe myocardial iron deposition: protocol for a randomised, controlled trial.
    Shakoor A; Zahoor M; Sadaf A; Alvi N; Fadoo Z; Rizvi A; Quadri F; Tipoo FA; Khurshid M; Sajjad Z; Colan S; Hasan BS
    BMJ Open; 2014 Dec; 4(12):e005360. PubMed ID: 25492271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the iron chelator deferiprone and the T-type calcium channel blocker efonidipine on cardiac function and Ca
    Khamseekaew J; Kumfu S; Palee S; Wongjaikam S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
    Cell Calcium; 2018 Jun; 72():18-25. PubMed ID: 29748130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice.
    Kumfu S; Chattipakorn S; Chinda K; Fucharoen S; Chattipakorn N
    Eur J Haematol; 2012 Jun; 88(6):535-48. PubMed ID: 22404220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined iron chelator and T-type calcium channel blocker exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice.
    Kumfu S; Khamseekaew J; Palee S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
    Eur J Pharmacol; 2018 Mar; 822():43-50. PubMed ID: 29366843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy.
    Oudit GY; Sun H; Trivieri MG; Koch SE; Dawood F; Ackerley C; Yazdanpanah M; Wilson GJ; Schwartz A; Liu PP; Backx PH
    Nat Med; 2003 Sep; 9(9):1187-94. PubMed ID: 12937413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice.
    Khamseekaew J; Kumfu S; Wongjaikam S; Kerdphoo S; Jaiwongkam T; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
    Eur J Pharmacol; 2017 Mar; 799():118-127. PubMed ID: 28192097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of iron overload cardiomyopathy: beneficial effects of iron chelating agent and calcium channel blocker on left ventricular dysfunction.
    Sugishita K; Asakawa M; Usui S; Takahashi T
    Int Heart J; 2009 Nov; 50(6):829-38. PubMed ID: 19952479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Iron Overload on Cardiac Calcium Regulation: Translational Insights Into Mechanisms and Management of a Global Epidemic.
    Khamseekaew J; Kumfu S; Chattipakorn SC; Chattipakorn N
    Can J Cardiol; 2016 Aug; 32(8):1009-16. PubMed ID: 26860778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferric iron uptake into cardiomyocytes of β-thalassemic mice is not through calcium channels.
    Kumfu S; Chattipakorn S; Fucharoen S; Chattipakorn N
    Drug Chem Toxicol; 2013 Jul; 36(3):329-34. PubMed ID: 23050671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy.
    Oudit GY; Trivieri MG; Khaper N; Liu PP; Backx PH
    J Mol Med (Berl); 2006 May; 84(5):349-64. PubMed ID: 16604332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron overload cardiomyopathy: Using the latest evidence to inform future applications.
    Kumfu S; Chattipakorn SC; Chattipakorn N
    Exp Biol Med (Maywood); 2022 Apr; 247(7):574-583. PubMed ID: 35130741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future treatment strategies for iron overload cardiomyopathy.
    Wongjaikam S; Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
    Eur J Pharmacol; 2015 Oct; 765():86-93. PubMed ID: 26291660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update.
    Gordan R; Wongjaikam S; Gwathmey JK; Chattipakorn N; Chattipakorn SC; Xie LH
    Heart Fail Rev; 2018 Sep; 23(5):801-816. PubMed ID: 29675595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of iron overload condition on liver toxicity and hepcidin/ferroportin expression in thalassemic mice.
    Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
    Life Sci; 2016 Apr; 150():15-23. PubMed ID: 26921633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron and oxidative stress in cardiomyopathy in thalassemia.
    Berdoukas V; Coates TD; Cabantchik ZI
    Free Radic Biol Med; 2015 Nov; 88(Pt A):3-9. PubMed ID: 26216855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amlodipine reduces cardiac iron overload in patients with thalassemia major: a pilot trial.
    Fernandes JL; Sampaio EF; Fertrin K; Coelho OR; Loggetto S; Piga A; Verissimo M; Saad ST
    Am J Med; 2013 Sep; 126(9):834-7. PubMed ID: 23830536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.